Get notified when PRME files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsPrime Medicine holds routine annual meeting, elects two directors through 2029
Filed June 8, 2026 · Period ending June 5, 2026 · ~1 min read
Key Changes
-
low
Michael Kelly and David Schenkein elected as Class I Directors for three-year terms ending 2029. Schenkein received notably higher withheld votes (22.6M vs 3M) but both passed comfortably.
Item 5.07 verify on EDGAR → -
low
Shareholders ratified PricewaterhouseCoopers LLP as independent auditor for 2026 with 99.7% approval (140M for, 101K against).
Item 5.07 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (THRM 10-Q) is open in full — no account needed.
Partner
Trade PRME commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 9, 2026 · How we verify